Clinical Trial Update: Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and End-Stage Renal Disease (MK-0431-073 AM1) [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing sitagliptin to glipizide in adults with type 2 diabetes mellitus and end-stage renal disease, with results posted after completion in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Glucotrol (glipizide)
• Januvia (sitagliptin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Diabetes Mellitus, Type 2, End-Stage Kidney Disease | Phase 3 | Status: COMPLETED | Results posted: 2012-05-03